Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Framework for Transition products commencing 1 February 2025

NHS England

This public procurement record has 2 releases in its history.

Award

21 Jan 2025 at 16:16

Award Notice
Tender

30 Sep 2024 at 12:02

Tender Notice
Summary of the contracting process

The NHS England has announced the award of the NHS National Framework for Transition products, which will commence on 1 February 2025. The framework covers pharmaceutical products (CPV classification: 33600000) and spans across various regions in the UK. The procurement process has been completed, with a framework agreement in place from 1 February 2025 to 31 May 2026. Key products within this framework include Eribulin Injection, Bosutinib Tablets, and Liraglutide Injection. The procurement was conducted using an open procedure, ensuring transparency and fair competition. The contracting authority is NHS England, headquartered at 7-8 Wellington Place, Leeds, UK.

This tender presents significant growth opportunities for businesses in the pharmaceutical sector. The framework is suited for suppliers who can provide high-quality pharmaceutical products, with an emphasis on price as the award criterion. With an option to extend the framework by up to an additional 24 months, businesses have the possibility to secure long-term contracts. The framework agreement includes multiple successful suppliers, including large corporations and SMEs, indicating diverse opportunities for various types of businesses to enter and thrive in the NHS supply chain. Participants are encouraged to engage with NHS England for further opportunities and support in delivering healthcare products.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework for Transition products commencing 1 February 2025

Notice Description

Project title: NHS National Framework for Transition products commencing 1 February 2025<br/>Offer reference number: CM/TNS/24/5713<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection<br/><br/>Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)<br/><br/>Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Lot Information

Lot 1

Project title: NHS National Framework for Transition products commencing 1 February 2025
Offer reference number: CM/TNS/24/5713
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:

CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection

Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)
Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)
Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04a41a
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/002071-2025
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£28,320,000 £10M-£100M
Lots Value
£28,320,000 £10M-£100M
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
21 Jan 20251 years ago
Submission Deadline
30 Oct 2024Expired
Future Notice Date
Not specified
Award Date
14 Jan 20251 years ago
Contract Period
1 Feb 2025 - 31 May 2026 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Postcode Area
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified
Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Supplier Information

Number of Suppliers
6
Supplier Names

Baxter Healthcare Ltd

Biocon

Dr.Reddy's Laboratories (UK) Limited

Sun Pharma UK Ltd

Thornton and Ross Ltd

Zentiva Pharma UK Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...